Vor Ort
Merkzettel Warenkorb
Produktbild: Novel and Re-Emerging Respiratory Viral Diseases

Novel and Re-Emerging Respiratory Viral Diseases

Aus der Reihe Novartis Foundation Symposium

223,99 €

inkl. gesetzl. MwSt., Versandkostenfrei

Beschreibung

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

01.05.2008

Herausgeber

Gregory R. Bock + weitere

Verlag

John Wiley & Sons

Seitenzahl

174

Maße (L/B/H)

22,9/15,7/1,3 cm

Gewicht

408 g

Auflage

1. Auflage

Sprache

Englisch

ISBN

978-0-470-06538-9

Beschreibung

Rezension

"This is a valuable account of how new viral pathogens are discovered and analyzed. It also describes how a highly infectious outbreak can be contained. This information will be invaluable in future outbreaks. This book is highly recommended for individuals involved in diagnosing and containing infectious viral diseases." ( Doody s , January 2009)

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

01.05.2008

Herausgeber

Verlag

John Wiley & Sons

Seitenzahl

174

Maße (L/B/H)

22,9/15,7/1,3 cm

Gewicht

408 g

Auflage

1. Auflage

Sprache

Englisch

ISBN

978-0-470-06538-9

Herstelleradresse

Libri GmbH
Europaallee 1
36244 Bad Hersfeld
DE

Email: GPSR Kontakt

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)
  • Produktbild: Novel and Re-Emerging Respiratory Viral Diseases

  • Symposium on Novel and re-emerging respiratory viral diseases, held at the Institute of Molecular and Cell Biology, Singapore, 23-25 April 2007.

    Editors: Gregory Bock (Organizer) and Jamie Goode.

    This meeting was based on a proposal made by Yee-Joo Tan and Wanjin Hong.

    Robert G. Webster Chair's introduction.

    Larry J. Anderson and Suxiang Tong Identification and characterization of novel viruses.

    Discussion.

    Edward C. Holmes The evolution of viral emergence.

    Discussion.

    Derek J. Smith, Jan C. de Jong, Alan S. Lapedes, Terry C. Jones, Colin A. Russell, Theo M. Bestebroer, Guus F. Rimmelzwaan, Albert D. M. E. Osterhaus and Ron A. M. Fouchier Antigenic artography of human and swine influenza A (H3N2) viruses.

    Discussion.

    Gabriele Neumann and Yoshihiro Kawaoka Influenza pandemics and control.

    Discussion.

    J. J. Skehel, S. Wharton, L. Calder and D. Stevens On the activation of membrane fusion by influenza haemagglutinin.

    Discussion.

    Yee Sin Leo Singapore SARS experience and preparation for future outbreak.

    Discussion.

    Yee-Joo Tan SARS lessons for a young virology laboratory in Singapore.

    Discussion.

    Ih-Jen Su How the SARS experience has helped preparations for future outbreaks: the Taiwan experience, with emphasis on the successful control of institutional outbreak of influenza in 2003/2004 using a stockpile of antivirals.

    Discussion.

    General discussion I.

    Yuelong Shu, Yu Lan, Leying Wen, Ye Zhang, Jie Dong, Xinsheng Zhao, Dayan Wang, Lihong Yao, Xiyan Li, Wei Wang, Xiuping Wang, Qi Wang, Shumin Duan, Jingjing Huang, Lei Yang, Hongjie Yu, Yuanji Guo, Weizhong Yang, Xiyan Xu, Nancy J. Cox, Xiaoping Dong, Yu Wang and Dexin Li Genetic and antigenic characterization of avian influenza A (H5N1) viruses isolated from humans in Mainland China.

    Discussion.

    J. S. M. Peiris and Y. Guan Emerging infectious diseases and the animal-human interface.

    Discussion.

    Erich Hoffmann, Hui-Ling Yen, Rachelle Salomon, Neziha Yilmaz and Robert G. Webster Transmission and pathogenicity of H5N1 influenza viruses.

    Discussion.

    John M. Wood Development of vaccine for a future influenza pandemic.

    Discussion.

    Final discussion.

    Index of contributors.

    Subject index.